BioCorRx Inc. (BICX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 244 transactions totaling $5.9M, demonstrating a bullish sentiment with $4.1M in net insider flow. The most recent transaction on Jun 28, 2024 involved a transaction of 10,204 shares valued at $0.
No significant insider buying has been recorded for BICX in the recent period.
No significant insider selling has been recorded for BICX in the recent period.
Based on recent SEC filings, insider sentiment for BICX is bullish with an Insider Alignment Score of 85/100 and a net flow of $4.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioCorRx Inc. (BICX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading BICX stock, having executed 244 transactions in the past 90 days. The most active insider is Louis C. Lucido (Executive), who has made 59 transactions totaling $4.5M.
Get notified when executives and directors at BICX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | Felix Lourdes | Executive | Award | 10,204 | $N/A | $0 | |
| Jun 28, 2024 | Ingargiola Luisa | Executive | Award | 10,204 | $N/A | $0 | |
| Jun 28, 2024 | C. Lucido Louis | Executive | Award | 34,016 | $N/A | $0 | |
| Jun 28, 2024 | C. Lucido Louis | Executive | Award | 10,204 | $N/A | $0 | |
| May 31, 2024 | C. Lucido Louis | Executive | Award | 22,831 | $N/A | $0 | |
| Apr 30, 2024 | C. Lucido Louis | Executive | Award | 21,552 | $N/A | $0 | |
| Mar 28, 2024 | Ingargiola Luisa | Executive | Award | 5,566 | $N/A | $0 | |
| Mar 28, 2024 | Felix Lourdes | Executive | Award | 5,566 | $N/A | $0 | |
| Mar 28, 2024 | C. Lucido Louis | Executive | Award | 18,553 | $N/A | $0 | |
| Mar 28, 2024 | C. Lucido Louis | Executive | Award | 5,566 | $N/A | $0 | |
| Mar 28, 2024 | Murthy Harsha | Executive | Award | 5,566 | $N/A | $0 | |
| Mar 28, 2024 | J. Galligan Joseph | Executive | Award | 5,566 | $N/A | $0 | |
| Feb 29, 2024 | C. Lucido Louis | Executive | Award | 16,892 | $N/A | $0 | |
| Jan 31, 2024 | C. Lucido Louis | Executive | Award | 18,269 | $N/A | $0 | |
| Jan 16, 2024 | C. Lucido Louis | Executive | Purchase | 126 | $0.70 | $88 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 47 | $5.0M | 83.8% |
Sale(S) | 76 | $867.0K | 14.5% |
Exercise(M) | 2 | $100.0K | 1.7% |
Award(A) | 118 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at BioCorRx Inc. are accumulating shares at an accelerated pace. With 9 insiders making 244 transactions totaling $5.0M in purchases versus $867.0K in sales, the net buying activity of $4.1M signals strong executive confidence. Louis C. Lucido (Executive) leads the buying activity with $4.5M in transactions across all time.